,i  #aah? ,,congress  #a/ ,session  ,h4 
,r4 #ebfi  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,augu/ #be1 #bjbc,mr4 
,curtis 7= himself & ,mr4 ,tonko7       
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,en]gy & ,comm]ce  ,a  
,,bill  ,to am5d ! ,f$]al ,food1 ,drug1 
& ,cosmetic ,act to provide = !         
e/abli%m5t & ma9t5ance ( a ,p$iatric    
,rese>* ,site ,network4  #a4 ,%ort title
 ,?is ,act may be cit$ z ! ,p$iatric    
,network ,support ,act4  #b4 ,p$iatric  
,rese>* ,site ,network ,sub*apt] ,a (   
*apt] ,v ( ! ,f$]al ,food1 ,drug1 &     
,cosmetic ,act 7#ba ,u4,s4,c4 #cea et   
seq47 is am5d$ by add+ at ! end !       
foll[+3  #ebd;,c4 ,p$iatric ,rese>*     
,site ,network  7a7 ,e/abli%m5t ,!      
,secret>y %all provide = ! e/abli%m5t & 
ma9t5ance ( a ,p$iatric ,rese>* ,site   
,network 9 :i*-- 7#a7 ! ,secret>y aw>ds 
grants to eligible entities2 &  7#b7    
?r\gh su* grants1 ! eligible entities   
collaborate on-- 7,a7 ! developm5t &    
dissem9ation ( guidance & educational   

mat]ials = ! purposes (--  7i7 enhanc+  
p$iatric cl9ical trials1 includ+ )      
respect to p$iatric /udy design &       
feasibility2  7ii7 id5tify+ & mitigat+  
*all5ges 9 p$iatric rese>* t delay      
p$iatric cl9ical trials2  7iii7 be/     
practices 9 ! conduct ( p$iatric cl9ical
 trials2  7iv7 improv+ ! process = !    
developm5t ( m$ical products2  7v7      
label+ innovative m$ical products2  7vi7
 accel]at+ m$ical product developm5t2 & 
7vii7 enhanc+ m$ical product safety2 &  
7,b7 su* o!r activities z may be det]m9$
 by ! ,secret>y = purposes ( enhanc+    
p$iatric cl9ical trials4  7b7 ,eligible 
entity ,to be eligible to receive a     
grant "u ?is section1 an entity %all    
meet ea* ( ! foll[+3 7#a7 ,! entity is--
  7,a7 an in/itution ( high] education z
 def9$ 9 subsection 7a7 or 7b7 ( section
 #aja ( ! ,high] ,education ,act (      
#aife2 or  7,b7 an organization describ$
 9 section #eja7;c77#c7 ( ! ,int]nal    
,rev5ue ,code ( #aihf & exempt f tax "u 
section #eja7;a7 ( su* ,code4  7#b7 ,!  

entity has exp]i5c$ p]sonnel1 & cl9ical 
& o!r te*nical exp]tise1 9 ! biom$ical  
sci5ces4  7#c7 ,! entity demon/rates to 
! ,secret>y's satisfaction t ! entity is
 capable ( c>ry+ out ! activities       
describ$ 9 subsection 7a77#b74  7c7     
,annual report ,n lat] ?an #ah mon?s    
aft] ! date ( enactm5t ( ?is section1 & 
annually !reaft]1 ! ,secret>y1 9        
collaboration ) ! grantees "u ?is       
section1 %all submit a report to !      
,committee on ,heal?1 ,education1       
,labor1 & ,p5sions ( ! ,s5ate & !       
,committee on ,en]gy & ,comm]ce ( !     
,h\se ( ,repres5tatives-- 7#a7 review+ !
 op]ations & activities ( ! ,p$iatric   
,rese>* ,site ,network 9 ! previ\s ye>2 
&  7#b7 address+ su* o!r issues relat+  
to ?is section z ! ,secret>y det]m9es to
 be appropriate4  7d7 ,def9ition ,9 ?is 
section1 ! t]m m$ical product means a   
drug 7includ+ a biological product71 a  
device 7includ+ a diagno/ic te/71 & any 
comb9ation product describ$ 9 section   
#ejc7;g74  7e7 ,au?orization (          

appropriations ,to c>ry out ?is section1
 !re is au?oriz$ to be appropriat$      
#b1jjj1jjj = ea* ( fiscal ye>s #bjbd    
?r\gh #bjbi4  4